ask="6.51"
ask_size="500"
average_daily_volume="73365"
bid="5.68"
bid_size="1000"
book_value="5.08"
change="-0.04"
change_from_200_day_moving_average="0.46"
change_from_50_day_moving_average="1.32"
change_from_52_week_high="-6.59"
change_From_52_week_low="2.50"
change_in_percent="-0.65%"
close="6.16"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-3.06"
ebitda="-20.26M"
eps_estimate_current_year="-3.75"
eps_estimate_next_quarter="-0.80"
eps_estimate_next_year="-2.57"
ex_dividend_date="N/A"
float_shares="6295000"
high="6.32"
high_52_weeks="12.75"
last_trade_date="3/1/2017"
last_trade_price="6.16"
last_trade_size="189"
last_trade_time="4:00pm"
low="5.73"
low_52_weeks="3.66"
market_capitalization="82.73M"
moving_average_200_day="5.70"
moving_average_50_day="4.84"
name="Aeglea BioTherapeutics
Inc."
notes="N/A"
one_year_target_price="17.00"
open="6.23"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+7.98%"
percent_change_from_50_day_moving_average="+27.17%"
percent_change_from_52_week_high="-51.69%"
percent_change_from_52_week_low="+68.31%"
previous_close="6.20"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.22"
price_per_sales="16.77"
revenue="4.97M"
shares_outstanding="13430000"
short_ratio="2.04"
stock_exchange="NGM"
symbol="AGLE"
volume="87356"
weeks_range_52="3.66 - 12.75"
